Calles, Ashleya Kaye A.
HRN: 22-41-20 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/22/2023
CEFUROXIME 1.5GM (VIAL)
10/22/2023
10/29/2023
IVT
210mg
Q8
UTI
Waiting Final Action